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Sir,
As the authors of the article “LDLR and ApoB are
Major Genetic Causes of Autosomal Dominant
Hypercholesterolemia in a Taiwanese Population”
in the October 2007 issue of the Journal of the
Formosan Medical Association,1 we found two num-
bering errors regarding the novel polymorphisms
of the LDLR gene we identified in patients with
autosomal dominant hypercholesterolemia.
In Table 4, the two novel polymorphisms of the
LDLR gene were originally numbered as AG1415
in exon 10 and CT2258 in exon 16. However,
these numbers are erroneous and they should be
relabeled as AG1374 (exon 10, Arg >Arg) and
CT2358 (exon 16, Ser>Ser), respectively.
The text describing the LDLR gene variants 
in the results section (page 803, lines 17–18 under
the LDLR gene variants subheading) should also
be corrected to “A>G at 1374 and C>T at 2358”).
Both of the polymorphisms were confirmed by
screening 50 control DNA samples (100 alleles)
and cross-matching in the LDLR mutation
database.2
As the information is important to the under-
standing of autosomal dominant hyperchol-
esterolemia in Taiwanese people, and as the
polymorphisms could also be incorporated into
LDLR mutation databases, we hereby write in to
formally correct our article.
We thank Professor Anne K. Soutar from the
Lipoprotein Group of the MRC Clinical Sciences
Center in Imperial College London for the dis-
cussion of our data.
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